Wednesday - July 29, 2026
New Antibody-drug Conjugate Shows Clinical Benefit for Advanced Platinum-resistant Ovarian Cancer
April 19, 2026
PHILADELPHIA, Pennsylvania, April 19 [Category: Medical] -- The American Association for Cancer Research posted the following news release:

* * *

New Antibody-drug Conjugate Shows Clinical Benefit for Advanced Platinum-resistant Ovarian Cancer

*

The investigational drug led to objective response and disease control in patients with late-stage disease

SAN DIEGO - Patients with advanced platinum-resistant ovarian cancer whose diseas . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products